Ashfaq Parkar is a pharmaceutical executive with 28 years of leadership experience in research and clinical development across various therapeutic areas, including immunology, inflammation, cardiovascular, and metabolism. Currently serving as the Global Product Leader for CV & Renal at CSL, Ashfaq previously led the Lung Fibrosis Development Program at Bristol Myers Squibb from 2020 to 2023. They have also held significant roles at Regeneron, Aventis, and Sanofi, where they demonstrated a strong ability to advance projects through effective global team leadership. Ashfaq is pursuing a D Phil in Biochemistry at the University of Oxford and is recognized for their analytical mindset, business acumen, and passion for developing top talent in the industry.
This person is not in any teams
This person is not in any offices